2019
DOI: 10.1017/s0033291719003179
|View full text |Cite|
|
Sign up to set email alerts
|

Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort

Abstract: Background The aim of the current study was to examine the heterogeneity of functional outcomes in first episode psychosis (FEP) patients and related clinical, neurocognitive and sociodemographic factors using a cluster analytic approach. Method A large sample of FEP patients (N = 209) was functionally reassessed 10 years after the first contact with an early intervention service. Multiple baseline, 3-year and 10-year follow-up variables were explored. Results The clust… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
13
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 16 publications
(15 citation statements)
references
References 42 publications
2
13
0
Order By: Relevance
“…As expected, based on literature and in previous research in our group, females were older at illness onset and admission to the PAFIP program 4,14 . Mean age at onset for females was 4 years higher than that for males.…”
Section: Discussionsupporting
confidence: 90%
See 3 more Smart Citations
“…As expected, based on literature and in previous research in our group, females were older at illness onset and admission to the PAFIP program 4,14 . Mean age at onset for females was 4 years higher than that for males.…”
Section: Discussionsupporting
confidence: 90%
“…The patients constituting the 10-year follow-up PAFIP cohort were reassessed between June 2014 and August 2018. The patients included in the referred period were invited for a reassessment after a time window ranging from 8 to 16 years after initial presentation 4 .…”
Section: Study Design and Settingmentioning
confidence: 99%
See 2 more Smart Citations
“…Schizophrenia is a heterogeneous disease, which varies greatly in its manifestation across patient groups, disease course, and incidence in different parts of the world [1,2]. Globally it was estimated that there were approximately 20 million people with schizophrenia in 2017, amounting to around 12,500 years lived with disability [2].…”
Section: Introductionmentioning
confidence: 99%